A new mouse unilateral model of diffuse alveolar damage of the lung

Autor: A. S. Chernov, A. A. Minakov, V. A. Kazakov, M. V. Rodionov, I. N. Rybalkin, T. N. Vlasik, D. V. Yashin, L. P. Saschenko, A. A. Kudriaeva, A. A. Belogurov, I. V. Smirnov, S. Ya. Loginova, V. N. Schukina, S. V. Savenko, S. V. Borisevich, K. A. Zykov, A. G. Gabibov, G. B. Telegin
Rok vydání: 2022
Předmět:
Zdroj: Inflammation Research. 71:627-639
ISSN: 1420-908X
1023-3830
Popis: The existing biological models of diffuse alveolar damage (DAD) in mice have many shortcomings. To offset these shortcomings, we have proposed a simple, nonsurgical, and reproducible method of unilateral total damage of the left lung in ICR mice. This model is based on the intrabronchial administration of a mixture of bacterial lipopolysaccharide (LPS) from the cell wall of S. enterica and α-galactosylceramide (inducing substances) to the left lung.Using computer tomography of the lungs with endobronchial administration of contrast material, we have been able to perform an operative intravital verification of the targeted delivery of the inducer. The model presented is characterized by more serious and homogeneous damage of the affected lung compared to the existing models of focal pneumonia; at the same time, our model is characterized by longer animal survival since the right lung remains intact.The model is also characterized by diffuse alveolar damage of the left lung, animal survival of 100%, abrupt increases in plasma levels of TNFa, INFg, and IL-6, and significant myocardial overload in the right heart. It can be used to assess the efficacy of innovative drugs for the treatment of DAD and ARDS as the clinical manifestations that are developed in patients infected with SARS-CoV-2. Morphological patterns of lungs in the noninfectious ("sterile") model of DAD induced by LPS simultaneously with α-galactosylceramide (presented here) and in the infectious model of DAD induced by SARS-CoV-2 have been compared.The DAD model we have proposed can be widely used for studying the efficacy of candidate molecules for the treatment of infectious respiratory diseases, such as viral pneumonias of different etiology, including SARS-CoV-2.
Databáze: OpenAIRE
Externí odkaz: